The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness

[1]  N. Freemantle,et al.  Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research , 2013, BMJ.

[2]  P. Austin.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments , 2013, Statistics in medicine.

[3]  D. Cook,et al.  The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. , 2013, Chest.

[4]  Jie Dong,et al.  Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. , 2018 .

[5]  B L De Stavola,et al.  Methods for dealing with time‐dependent confounding , 2013, Statistics in medicine.

[6]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[7]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[8]  J. Rello,et al.  Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. , 2012, The Journal of infection.

[9]  E. Ruokonen,et al.  Corticosteroid therapy in intensive care unit patients with PCR‐confirmed influenza A(H1N1) infection in Finland , 2011, Acta anaesthesiologica Scandinavica.

[10]  S. Yun,et al.  Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. , 2011, American journal of respiratory and critical care medicine.

[11]  L. Brochard,et al.  Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. , 2011, American journal of respiratory and critical care medicine.

[12]  J. Chiche,et al.  Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection , 2010, Intensive Care Medicine.

[13]  G. Guyatt,et al.  Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. , 2010, Journal of critical care.

[14]  D. Annane,et al.  InFACT: a global critical care research response to H1N1 , 2010, The Lancet.

[15]  R. Perez-Padilla,et al.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. , 2009, The New England journal of medicine.

[16]  Lyn Finelli,et al.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. , 2009, The New England journal of medicine.

[17]  S. Lapinsky,et al.  Critically Ill patients with 2009 influenza A(H1N1) in Mexico. , 2009, JAMA.

[18]  M. Meade,et al.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada. , 2009, JAMA.

[19]  Svetlana K. Eden,et al.  Immortal time bias in critical care research: Application of time-varying Cox regression for observational cohort studies* , 2009, Critical care medicine.

[20]  W. Linde‐Zwirble.  When is simple too simple? Immortal time bias in critical care. , 2009, Critical care medicine.

[21]  Lung.  Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome , 2009 .

[22]  J. Rello,et al.  Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain , 2009, Critical care.

[23]  Djillali Annane,et al.  Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. , 2009, JAMA.

[24]  J. Craig,et al.  Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis* , 2009, Critical care medicine.

[25]  M. Tunks,et al.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2008 update--highlights for primary care. , 2008, Canadian respiratory journal.

[26]  J. Moran,et al.  Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis , 2008, BMJ : British Medical Journal.

[27]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[28]  A. Aggarwal,et al.  Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta‐analysis , 2007, Respirology.

[29]  G. Meduri,et al.  Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. , 2007, Chest.

[30]  Peter C Austin,et al.  A comparison of propensity score methods: a case‐study estimating the effectiveness of post‐AMI statin use , 2006, Statistics in medicine.

[31]  D. Annane,et al.  Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome* , 2006, Critical care medicine.

[32]  F. Blasi,et al.  Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. , 2005, American journal of respiratory and critical care medicine.

[33]  W. Zin,et al.  Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. , 2003, American journal of respiratory and critical care medicine.

[34]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[35]  G. Chrousos,et al.  Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. , 2002, American journal of respiratory and critical care medicine.

[36]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[37]  J. Robins,et al.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.

[38]  G. Meduri,et al.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. , 1998, JAMA.

[39]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[40]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[41]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[42]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[43]  J. Stockman,et al.  Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009 , 2011 .

[44]  L. Boulet,et al.  Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. , 2010, Canadian respiratory journal.

[45]  Abstr Act,et al.  Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand , 2009 .

[46]  Sean Keenan,et al.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.

[47]  R. Hyzy,et al.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. , 2006, The New England journal of medicine.